Bristol Myers Squibb announced that Christopher Boerner, Ph.D., as of November 1, Boerner will be Chief Executive Officer of Bristol Myers Squibb. About Christopher Boerner, Ph.D.: Christopher Boerner has served as EVP, Chief Operating Officer and CEO-elect since April 26, 2023. He was appointed EVP, Chief Commercialization Officer on August 28, 2018, where he led the worldwide Commercial and Medical organizations and was responsible for driving growth across the company?s key franchises.

Boerner previously served as head of international markets at Bristol Myers Squibb, accountable for international commercial activities. Prior to that, he served as head of U.S. commercial markets, responsible for U.S. sales and marketing, government affairs and market access. He joined the company in February 2015.

From 2010 to 2015, Boerner served in leadership roles of increasing responsibility at Seattle Genetics Inc. From 2002 to 2010, he served in marketing leadership roles at Genentech, a member of the Roche Group, focused on strategy, development and commercialization across multiple oncology products and immunology. Earlier in his career, Boerner worked for McKinsey & Company, serving global pharmaceutical and biotechnology clients. Boerner received his Ph.D. and MA in business administration from the Haas School of Business at the University of California, Berkeley, and holds a BA in economics and history from Washington University in St.

Louis.